Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2017, Article ID 6180904, 10 pages
https://doi.org/10.1155/2017/6180904
Clinical Study

Higher Ratio of Abdominal Subcutaneous to Visceral Adipose Tissue Related with Preservation of Islet β-Cell Function in Healthy Individuals

1Endocrinology Department, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China
2Centre for Eye Research Australia, Faculty of Medicine, Dentistry and Health Science, The University of Melbourne, East Melbourne, VIC 3002, Australia
3Box Hill Hospital Eastern Health, Box Hill, VIC 3128, Australia
4Endocrinology Department, The Affiliated Hospital of Guizhou Medical University, Guangyang 550000, China

Correspondence should be addressed to Yanbing Li; moc.621@byl40dsae

Received 24 July 2017; Accepted 30 October 2017; Published 28 December 2017

Academic Editor: Rosaria Meccariello

Copyright © 2017 Juan Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. Yang, J. Lu, J. Weng et al., “Prevalence of diabetes among men and women in China,” The New England Journal of Medicine, vol. 362, no. 12, pp. 1090–1101, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Gastaldelli, E. Ferrannini, Y. Miyazaki, M. Matsuda, and R. A. DeFronzo, “Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study,” Diabetologia, vol. 47, no. 1, pp. 31–39, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. A. M. Kanaya, D. Herrington, E. Vittinghoff et al., “Understanding the high prevalence of diabetes in U.S. south Asians compared with four racial/ethnic groups: the MASALA and MESA studies,” Diabetes Care, vol. 37, no. 6, pp. 1621–1628, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. F. B. Hu, “Globalization of diabetes: the role of diet, lifestyle, and genes,” Diabetes Care, vol. 34, no. 6, pp. 1249–1257, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. J. A. Nazare, J. D. Smith, A. L. Borel et al., “Ethnic influences on the relations between abdominal subcutaneous and visceral adiposity, liver fat, and cardiometabolic risk profile: the international study of prediction of intra-abdominal adiposity and its relationship with cardiometabolic risk/intra-abdominal adiposity,” The American Journal of Clinical Nutrition, vol. 96, no. 4, pp. 714–726, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. T. T. Tran, Y. Yamamoto, S. Gesta, and C. R. Kahn, “Beneficial effects of subcutaneous fat transplantation on metabolism,” Cell Metabolism, vol. 7, no. 5, pp. 410–420, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. K. I. Stanford, R. J. Middelbeek, K. L. Townsend et al., “A novel role for subcutaneous adipose tissue in exercise-induced improvements in glucose homeostasis,” Diabetes, vol. 64, no. 6, pp. 2002–2014, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Kim, B. Cho, H. Lee et al., “Distribution of abdominal visceral and subcutaneous adipose tissue and metabolic syndrome in a Korean population,” Diabetes Care, vol. 34, no. 2, pp. 504–506, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. T. McLaughlin, C. Lamendola, A. Liu, and F. Abbasi, “Preferential fat deposition in subcutaneous versus visceral depots is associated with insulin sensitivity,” The Journal of Clinical Endocrinology & Metabolism, vol. 96, no. 11, pp. E1756–E1760, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. T. M. Abraham, A. Pedley, J. M. Massaro, U. Hoffmann, and C. S. Fox, “Association between visceral and subcutaneous adipose depots and incident cardiovascular disease risk factors,” Circulation, vol. 132, no. 17, pp. 1639–1647, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. A. J. G. Hanley, L. E. Wagenknecht, J. M. Norris et al., “Insulin resistance, beta cell dysfunction and visceral adiposity as predictors of incident diabetes: the insulin resistance atherosclerosis study (IRAS) family study,” Diabetologia, vol. 52, no. 10, pp. 2079–2086, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Miazgowski, B. Krzyżanowska-Świniarska, J. Dziwura-Ogonowska, and K. Widecka, “The associations between cardiometabolic risk factors and visceral fat measured by a new dual-energy X-ray absorptiometry-derived method in lean healthy Caucasian women,” Endocrine, vol. 47, no. 2, pp. 500–505, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. M. M. Ibrahim, “Subcutaneous and visceral adipose tissue: structural and functional differences,” Obesity Reviews, vol. 11, no. 1, pp. 11–18, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. E. S. Freedland, “Role of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: implications for controlling dietary carbohydrates: a review,” Nutrition & Metabolism, vol. 1, no. 1, p. 12, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Sandeep, K. Gokulakrishnan, K. Velmurugan, M. Deepa, and V. Mohan, “Visceral & subcutaneous abdominal fat in relation to insulin resistance & metabolic syndrome in non-diabetic south Indians,” The Indian Journal of Medical Research, vol. 131, pp. 629–635, 2010. View at Google Scholar
  16. A. Amutha, M. K. Ali, R. Unnikrishnan et al., “Insulin sensitivity and secretion in youth onset type 2 diabetes with and without visceral adiposity,” Diabetes Research and Clinical Practice, vol. 109, no. 1, pp. 32–39, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. A. M. Curran, M. F. Ryan, E. Drummond et al., “Uncovering factors related to pancreatic beta-cell function,” PLoS One, vol. 11, no. 8, article e161350, 2016. View at Publisher · View at Google Scholar · View at Scopus
  18. D. L. Christensen, D. Faurholt-Jepsen, K. Faerch et al., “Insulin resistance and beta-cell function in different ethnic groups in Kenya: the role of abdominal fat distribution,” Acta Diabetologica, vol. 51, no. 1, pp. 53–60, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. N. J. van der Zijl, G. H. Goossens, C. C. Moors et al., “Ectopic fat storage in the pancreas, liver, and abdominal fat depots: impact on β-cell function in individuals with impaired glucose metabolism,” The Journal of Clinical Endocrinology & Metabolism, vol. 96, no. 2, pp. 459–467, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. B. Vahlberg, B. Lindmark, L. Zetterberg, K. Hellström, and T. Cederholm, “Body composition and physical function after progressive resistance and balance training among older adults after stroke: an exploratory randomized controlled trial,” Disability and Rehabilitation, vol. 39, no. 12, pp. 1207–1214, 2017. View at Publisher · View at Google Scholar · View at Scopus
  21. D. R. Matthews, J. P. Hosker, A. S. Rudenski, B. A. Naylor, D. F. Treacher, and R. C. Turner, “Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man,” Diabetologia, vol. 28, no. 7, pp. 412–419, 1985. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Matsuda and R. A. DeFronzo, “Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp,” Diabetes Care, vol. 22, no. 9, pp. 1462–1470, 1999. View at Publisher · View at Google Scholar · View at Scopus
  23. D. I. Phillips, P. M. Clark, C. N. Hales, and C. Osmond, “Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion,” Diabetic Medicine, vol. 11, no. 3, pp. 286–292, 1994. View at Publisher · View at Google Scholar · View at Scopus
  24. S. M. Grundy, J. I. Cleeman, S. R. Daniels et al., “Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement,” Circulation, vol. 112, no. 17, pp. 2735–2752, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. B. M. Kaess, A. Pedley, J. M. Massaro, J. Murabito, U. Hoffmann, and C. S. Fox, “The ratio of visceral to subcutaneous fat, a metric of body fat distribution, is a unique correlate of cardiometabolic risk,” Diabetologia, vol. 55, no. 10, pp. 2622–2630, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. Miyazaki, A. Mahankali, M. Matsuda et al., “Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients,” The Journal of Clinical Endocrinology & Metabolism, vol. 87, no. 6, pp. 2784–2791, 2002. View at Publisher · View at Google Scholar
  27. L. E. Gyllenhammer, T. L. Alderete, C. M. Toledo-Corral, M. Weigensberg, and M. I. Goran, “Saturation of subcutaneous adipose tissue expansion and accumulation of ectopic fat associated with metabolic dysfunction during late and post-pubertal growth,” International Journal of Obesity, vol. 40, no. 4, pp. 601–606, 2016. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Virtue and A. Vidal-Puig, “Adipose tissue expandability, lipotoxicity and the metabolic syndrome—an allostatic perspective,” Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, vol. 1801, no. 3, pp. 338–349, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. L. Heilbronn, S. R. Smith, and E. Ravussin, “Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus,” International Journal of Obesity, vol. 28, no. S4, pp. S12–S21, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Miranda, M. R. Chacon, J. Gomez et al., “Human subcutaneous adipose tissue LPIN1 expression in obesity, type 2 diabetes mellitus, and human immunodeficiency virus--associated lipodystrophy syndrome,” Metabolism, vol. 56, no. 11, pp. 1518–1526, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. R. Retnakaran, S. Shen, A. J. Hanley, V. Vuksan, J. K. Hamilton, and B. Zinman, “Hyperbolic relationship between insulin secretion and sensitivity on oral glucose tolerance test,” Obesity, vol. 16, no. 8, pp. 1901–1907, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. S. K. Malin, S. Finnegan, C. E. Fealy, J. Filion, M. B. Rocco, and J. P. Kirwan, “β-cell dysfunction is associated with metabolic syndrome severity in adults,” Metabolic Syndrome and Related Disorders, vol. 12, no. 2, pp. 79–85, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. L. X. Cubeddu and I. S. Hoffmann, “Impact of traits of metabolic syndrome on β-cell function and insulin resistance in normal fasting, normal glucose tolerant subjects,” Metabolic Syndrome and Related Disorders, vol. 10, no. 5, pp. 344–350, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. H. Kaneto, “Pancreatic β-cell glucose toxicity in type 2 diabetes mellitus,” Current Diabetes Reviews, vol. 11, no. 1, pp. 2–6, 2015. View at Publisher · View at Google Scholar
  35. G. Bardini, C. M. Rotella, and S. Giannini, “Dyslipidemia and diabetes: reciprocal impact of impaired lipid metabolism and beta-cell dysfunction on micro- and macrovascular complications,” The Review of Diabetic Studies, vol. 9, no. 2-3, pp. 82–93, 2012. View at Publisher · View at Google Scholar
  36. K. Nowotny, T. Jung, A. Hohn, D. Weber, and T. Grune, “Advanced glycation end products and oxidative stress in type 2 diabetes mellitus,” Biomolecules, vol. 5, no. 1, pp. 194–222, 2015. View at Publisher · View at Google Scholar · View at Scopus
  37. I. Lingvay, V. Esser, J. L. Legendre et al., “Noninvasive quantification of pancreatic fat in humans,” The Journal of Clinical Endocrinology & Metabolism, vol. 94, no. 10, pp. 4070–4076, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. R. A. DeFronzo, J. D. Tobin, and R. Andres, “Glucose clamp technique: a method for quantifying insulin secretion and resistance,” American Journal of Physiology - Gastrointestinal and Liver Physiology, vol. 237, no. 3, pp. G214–G223, 1979. View at Google Scholar
  39. M. Heni, J. Machann, H. Staiger et al., “Pancreatic fat is negatively associated with insulin secretion in individuals with impaired fasting glucose and/or impaired glucose tolerance: a nuclear magnetic resonance study,” Diabetes/Metabolism Research and Reviews, vol. 26, no. 3, pp. 200–205, 2010. View at Publisher · View at Google Scholar · View at Scopus